Status:
COMPLETED
Enamel Matrix Derivative in Non-surgical Periodontal Treatment
Lead Sponsor:
Medical University of Vienna
Conditions:
Periodontitis
Eligibility:
All Genders
25-75 years
Phase:
NA
Brief Summary
The aim of the study is to investigate the effect of enamel matrix derivative in addition to scaling and root planing in comparison to scaling and root planing only in periodontitis patients that have...
Detailed Description
Enamel matrix derivative (EMD) have already been widely applied as a regenerative bio-modulator in periodontal surgery and have been demonstrated to enhance periodontal regeneration. Recently, also it...
Eligibility Criteria
Inclusion
- Periodontitis stage III
- Patients that have completed initial periodontal therapy, and have remaining periodontal pockets of ≥6mm up to 9mm PPD
- Given written informed consent form for participation in the study
Exclusion
- Systemic antibiotics within the previous 3 months
- Pregnant or breastfeeding women
- Any current or past clinically significant pathology/disease (comorbidity) that, in the opinion of the periodontists, might confound the results or poses an additional risk to the subject during participation in the study, such as renal insufficiency, malignancy, rheumatoid osteoarthritis, human immunodeficiency syndrome.
- Patients with at least one tooth of mobility grade 0 or 1 and/or furcation involvement grade 0 or I according to Hamp
Key Trial Info
Start Date :
September 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04449393
Start Date
September 15 2020
End Date
July 1 2022
Last Update
October 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinic of Dentistry Vienna
Vienna, Austria, 1090